Drug repurposing approach to target FtsZ cell division protein from Salmonella Typhi

Keyphrases

• Antibacterial Activity 33%
• Antibacterial Agents 33%
• Antibacterial Drugs 33%
• Bacterial Culture 33%
• Bacterial Cytokinesis 33%
• Benzethonium Chloride 100%
• Binding Energy 33%
• Broad-spectrum Antimicrobials 33%
• Cell Division 33%
• Cell Division Protein 100%
• Docking Dynamics 33%
• Drug Repurposing 100%
• Drug Screening 33%
• Drug Target 33%
• DrugBank 33%
• Escherichia Coli ATCC 25922 33%
• FDA-approved Drugs 33%
• FtsZ 100%
• GTPase Activity 33%
• Helix 33%
• In Silico 33%
• Infectious Diseases 33%
• MIC Values 33%
• Molecular Docking 33%
• Molecular Dynamics Simulation 33%
• Multidrug-resistant Pathogens 66%
• New Antibacterials 33%
• Pharmacogenetic Testing 33%
• Promising Strategies 33%
• Repurposing Approaches 100%
• Salmonella Typhi (S. Typhi) 100%
• Staphylococcus Aureus 33%

Medicine and Dentistry

• Antibacterial Activity 33%
• Antiinfective Agent 66%
• Bacterium Culture 33%
• Benzethonium Chloride 100%
• Binding Energy 33%
• Carboxy Terminal Sequence 33%
• Cell Division 100%
• Cleft 33%
• Cytokinesis 33%
• Docking (Molecular) 33%
• Drug Repositioning 100%
• Escherichia coli 33%
• Guanosine Triphosphatase 33%
• Helix 33%
• In Silico 33%
• Infection 33%
• Pathogen 66%
• Pharmacophore 33%
• Salmonella Enterica Serovar Typhi 100%
• Staphylococcus Aureus 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Antibacterial Activity 33%
• Antiinfective Agent 66%
• Benzethonium Chloride 100%
• Drug Repositioning 100%
• Escherichia coli 33%
• Guanosine Triphosphatase 33%
• Infection 33%
• Infectious Agent 66%
• Salmonella Enterica Serovar Typhi 100%
• Staphylococcus Aureus 33%